metastatic/advanced - breast cancer (mBC) | |
metastatic/advanced - breast cancer (mBC) | |
trastuzumab deruxtecan | DESTINY-Breast04 |
Study type:
delta: difference in rate or median (if available)
- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy -